{"database": "lobbying", "table": "lobbying_activities", "rows": [[953831, "5e0b1b25-aef5-4a76-94e8-52a7aa381ad5", "Q2", "WILLIAMS AND JENSEN, PLLC", 41454, "CEPHALON INC.", 2010, "second_quarter", "CPT", "Legislation concerning patent settlements between brand name and generic pharmaceutical companies including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2010-07-15T08:50:41.777000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["953831"], "units": {}, "query_ms": 2.7457691030576825, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}